These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

51 related articles for article (PubMed ID: 2958917)

  • 21. Adaptive and pathological alterations in experimental cardiac hypertrophy.
    Jacob R; Kissling G; Ebrecht G; Holubarsch C; Medugorac I; Rupp H
    Adv Myocardiol; 1983; 4():55-77. PubMed ID: 6222443
    [No Abstract]   [Full Text] [Related]  

  • 22. The effects of hypertrophy on myocardial energy utilization.
    Gunning JF; Coleman HN
    Recent Adv Stud Cardiac Struct Metab; 1972; 1():190-9. PubMed ID: 4283435
    [No Abstract]   [Full Text] [Related]  

  • 23. Stable left ventricular hypertrophy in the dog. Experiental production, time course, and natural history.
    O'Kane HO; Geha AS; Kleiger RE; Abe T; Salaymeh MT; Malik AB
    J Thorac Cardiovasc Surg; 1973 Feb; 65(2):264-71. PubMed ID: 4265344
    [No Abstract]   [Full Text] [Related]  

  • 24. Differences between pathological and physiological cardiac hypertrophy: novel therapeutic strategies to treat heart failure.
    McMullen JR; Jennings GL
    Clin Exp Pharmacol Physiol; 2007 Apr; 34(4):255-62. PubMed ID: 17324134
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quantitative histology of the hypertrophied human heart.
    Pearlman ES; Weber KT; Janicki JS
    Fed Proc; 1981 May; 40(7):2042-7. PubMed ID: 6453024
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Biochemical and electron microscopical characteristics of mitochondria of different regions of the dog heart in experimental hypertrophy].
    Kopteva LA; Biriuzova VI; Melekhov VV
    Biull Eksp Biol Med; 1970 Jul; 70(7):43-7. PubMed ID: 4250989
    [No Abstract]   [Full Text] [Related]  

  • 27. Correlation of alpha-skeletal actin expression, ventricular fibrosis and heart function with the degree of pressure overload cardiac hypertrophy in rats.
    Stilli D; Bocchi L; Berni R; Zaniboni M; Cacciani F; Chaponnier C; Musso E; Gabbiani G; Clément S
    Exp Physiol; 2006 May; 91(3):571-80. PubMed ID: 16452123
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Features of the papillary trabecular apparatus of the cardiac ventricles under normal conditions and in hypertrophy].
    Galankin VN
    Arkh Patol; 1972; 34(9):30-5. PubMed ID: 4264807
    [No Abstract]   [Full Text] [Related]  

  • 29. Mechanism of physiologic versus pathologic ventricular hypertrophy process: enhanced or depressed myosin ATPase activity and contractility governed by type, degree and duration of inciting stress.
    Wikman-Coffelt J; Laks MM; Riemenschneider TH; Mason DT
    Basic Res Cardiol; 1980; 75(1):149-56. PubMed ID: 6446284
    [No Abstract]   [Full Text] [Related]  

  • 30. Physio-anatomical changes in cardiac hypertrophy.
    Taha J; Mansour R
    Middle East J Anaesthesiol; 1984 Jun; 7(5):319-27. PubMed ID: 6241650
    [No Abstract]   [Full Text] [Related]  

  • 31. Protein synthesis in cardiac hypertrophy.
    Schreiber SS; Morkin E
    Circ Res; 1972 Oct; 31(4):629-30. PubMed ID: 4263050
    [No Abstract]   [Full Text] [Related]  

  • 32. [Cardiac hypertrophy].
    Sakoda T; Masuyama T
    Nihon Rinsho; 2005 Mar; 63 Suppl 3():559-64. PubMed ID: 15813129
    [No Abstract]   [Full Text] [Related]  

  • 33. Physiological versus pathological myocardial hypertrophy.
    Wikman-Coffelt J; Laks MM; Riemenschneider T; Mason DT
    Adv Myocardiol; 1980; 1():469-76. PubMed ID: 6446742
    [No Abstract]   [Full Text] [Related]  

  • 34. Recovery of myosin ATPase after relief of pressure-overload hypertrophy and failure.
    Carey RA; Bove AA; Coulson RL; Spann JF
    Am J Physiol; 1978 Jun; 234(6):H711-7. PubMed ID: 149505
    [No Abstract]   [Full Text] [Related]  

  • 35. [Deterioration and improvement of cardiac hypertrophy].
    Kimata S; Kawana M; Taira A; Ishizuka H; Hirosawa K; Yazaki Y; Tsuchimochi H; Koyanagi H; Hashimoto A
    Kokyu To Junkan; 1987 Jul; 35(7):723-33. PubMed ID: 2958917
    [No Abstract]   [Full Text] [Related]  

  • 36. Cellular and subcellular basis of myocardial hypertrophy. Introduction .
    Alpert NR
    Fed Proc; 1986 Oct; 45(11):2561-2. PubMed ID: 2944765
    [No Abstract]   [Full Text] [Related]  

  • 37. The cardiac hypertrophy process. Analyses of factors determining pathological vs. physiological development.
    Wikman-Coffelt J; Parmley WW; Mason DT
    Circ Res; 1979 Dec; 45(6):697-707. PubMed ID: 159142
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.